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A B S T R A C T
Background
Singing is a complex physical activity dependent on the use of the lungs for air supply to regulate airflow and create large lung volumes.
In singing, exhalation is active and requires active diaphragm contraction and good posture. Chronic obstructive pulmonary disease
(COPD) is a progressive, chronic lung disease characterised by airflow obstruction. Singing is an activity with potential to improve
health outcomes in people with COPD.
Objectives
To determine the effect of singing on health-related quality of life and dyspnoea in people with COPD.
Search methods
We identified trials from the Cochrane Airways Specialised Register, ClinicalTrials.gov, theWorld Health Organization trials portal and
PEDro, from their inception to August 2017. We also reviewed reference lists of all primary studies and review articles for additional
references.
Selection criteria
We included randomised controlled trials in people with stable COPD, in which structured supervised singing training of at least
four sessions over four weeks’ total duration was performed. The singing could be performed individually or as part of a group (choir)
facilitated by a singing leader. Studies were included if they compared: 1) singing versus no intervention (usual care) or another control
intervention; or 2) singing plus pulmonary rehabilitation versus pulmonary rehabilitation alone.
Data collection and analysis
Two review authors independently screened and selected trials for inclusion, extracted outcome data and assessed risk of bias. We
contacted authors of trials for missing data. We calculated mean differences (MDs) using a random-effects model. We were only able
to analyse data for the comparison of singing versus no intervention or a control group.
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Main results
Three studies (a total of 112 participants) were included. All studies randomised participants to a singing group or a control group.
The comparison groups included a film workshop, handcraft work, and no intervention. The frequency of the singing intervention in
the studies ranged from 1 to 2 times a week over a 6 to 24 week period. The duration of each singing session was 60 minutes.
All studies included participants diagnosed with COPD with a mean age ranging from 67 to 72 years and a mean forced expiratory
volume in one second (FEV1) ranging from 37% to 64% of predicted values. The sample size of included studies was small (33 to 43
participants) and overall study quality was low to very low. Blinding of personnel and participants was not possible due to the physical
nature of the intervention, and selection and reporting bias was present in two studies.
For the primary outcome of health-related quality of life, there was no statistically significant improvement in the StGeorge’s Respiratory
Questionnaire total score (mean difference (MD) -0.82, 95% confidence interval (CI) -4.67 to 3.02, 2 studies, n = 58, low-quality
evidence). However, there was a statistically significant improvement in the SF-36 Physical Component Summary (PCS) score favouring
the singing group (MD 12.64, 95% CI 5.50 to 19.77, 2 studies, n = 52, low-quality evidence). Only one study reported results for the
other primary outcome of dyspnoea, in which the mean improvement in Baseline Dyspnoea Index (BDI) score favouring the singing
group was not statistically significant (MD 0.40, 95% CI -0.65 to 1.45, 1 study, n = 30, very low-quality evidence).
No studies examined any long-term outcomes and no adverse events or side effects were reported.
Authors’ conclusions
There is low to very low-quality evidence that singing is safe for people with COPD and improves physical health (as measured by
the SF-36 physical component score), but not dyspnoea or respiratory-specific quality of life. The evidence is limited due to the low
number of studies and the small sample size of each study. No evidence exists examining the long-term effect of singing for people with
COPD. The absence of studies examining singing performed in conjunction with pulmonary rehabilitation precludes the formulation
of conclusions about the effects of singing in this context. More randomised controlled trials with larger sample sizes and long-term
follow-up, and trials examining the effect of singing in addition to pulmonary rehabilitation, are required to determine the effect of
singing on health-related quality of life and dyspnoea in people with COPD.
P L A I N L A N G U A G E S U M M A R Y
Singing for COPD
Singing uses the lungs to provide airflow to produce musical words or sounds with the voice. Singing can require a lot of effort for muscle
contraction and co-ordination. This may benefit people with chronic obstructive pulmonary disease (COPD) in a manner similar to
that of breathing exercises. Singing is said to be beneficial for health but we need evidence for this before it can be recommended
specifically to address health conditions. We planned to examine whether singing had any effect on quality of life or breathlessness in
people with COPD. We included three studies with a total of 112 participants. Participants were randomly assigned to singing training
or to a non-singing control group. The control groups were either a film workshop, handcraft work, or nothing at all. The singing was
performed in groups, once to twice a week for one hour, for a minimum of six weeks. There was diversity in the results of the studies
and we were unable to combine many results in ’meta-analyses’. A meta-analysis is a statistical analysis which combines the results of
two or more separate studies to give a pooled result. Some studies showed improvements in some aspects of quality of life, while others
showed no improvement. Breathlessness was only measured in one study and no improvement was found. The studies did not report
whether any effects lasted for a long time after the singing training was completed. No studies reported any side effects from singing, so
singing appears to be safe for people with COPD. The studies were of low quality due to the small number of participants and missing
information about the methods and some of the outcomes. We were unable to find enough evidence to sufficiently determine the effect
of singing in people with COPD. More studies are required and they should concentrate on enrolling larger numbers of people.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Singing compared with control for chronic obstructive pulmonary disease (COPD)
Patient or population: people with stable COPD
Settings: hospital and community
Intervention: singing
Comparison: control
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Singing
Health- related quality
of life (respiratory spe-
cific)
St George’s Respiratory
Quest ionnaire (SGRQ;
total score)
Scale f rom 0-100
Lower value post inter-
ven-
t ion is favourable, indi-
cat ing improvement in
health-related quality of
lif e
Follow-up: end of inter-
vent ion (range 6 to 24
weeks)
The mean change in
SGRQ (total score)
ranged across control
groups f rom -5.0 to -0.4
The mean change in
SGRQ (total score) in
the intervent ion groups
was 0.8 units higher (3.
0 units lower to 4.7
units higher)
58
(2 studies)
⊕⊕©©
low1,2
The minimal important
dif f erence is 4 units
lower
Health- related quality
of life (generic)
SF-36 (Physical Com-
ponent Summary (PCS)
score)
The mean change in SF-
36 (PCS score) ranged
across control groups
f rom -3.8 to -2.5
The mean change in SF-
36 (PCS score) in the in-
tervent ion groups was
12.6 units higher (5.
5 units higher to 19.8
52
(2 studies)
⊕⊕©©
low3,4
The minimal important
dif f erence is 4 units
higher
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Scale f rom 0-100
Higher value post inter-
ven-
t ion is favourable, indi-
cat ing improvement in
health-related quality of
lif e
Follow-up: end of inter-
vent ion (range 6 to 8
weeks)
units higher)
Health- related quality
of life (generic)
SF-36 (Mental Com-
ponent Sumary (MCS)
score)
Scale f rom 0-100
Higher value post inter-
ven-
t ion is favourable, indi-
cat ing improvement in
health-related quality of
lif e
Follow-up: end of in-
tervent ion (range 6-8
weeks)
The mean change in SF-
36 (MCS score) ranged
across control groups
f rom -3.2 to 4.3
The mean change in
SF-36 (MCS score) in
the intervent ion groups
was 5.4 units higher (3.
9 units lower to 14.7
units higher)
52
(2 studies)
⊕⊕©©
low2,4
The minimal important
dif f erence is 4 units
higher
Dyspnoea
Basal Dyspnea Index
(BDI) (score)
Scale f rom 0-12
Higher value post inter-
ven-
t ion is favourable, indi-
cat ing improvement in
dyspnoea
Follow-up: end of inter-
vent ion (24 weeks)
The mean change in BDI
(score) was 0.3
The mean change in
BDI (score) in the in-
tervent ion groups was
0.4 units higher (0.7
units lower to 1.5 units
higher)
30
(1 study)
⊕©©©
very low5,6
The minimal important
dif f erence is 1 unit
higher
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* The corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 One study showed lim itat ions in design: select ion and detect ion bias unknown (risk of bias -1)
2 Meta-anlaysis was lim ited to few studies with small sample sizes and wide conf idence intervals (imprecision -1)
3 Meta-analysis was lim ited to few studies with small sample sizes (imprecision -1)
4 One study showed report ing bias (risk of bias -1)
5 Study showed lim itat ions in design: select ion and detect ion bias unknown (risk of bias -1)
6 No meta-analysis as only one study (imprecision -2)
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B A C K G R O U N D
Description of the condition
Chronic obstructive pulmonary disease (COPD) is a progressive
lung disease characterised by airflow limitation that is not fully re-
versible and is associated with an abnormal inflammatory response
of the lungs to noxious particles or gases (GOLD 2017). The
prevalence of COPD has been reported as ranging from 0.2% to
37%, and varies widely across countries and populations (Rycroft
2012). Prevalence and incidence is greatest in men and those aged
75 years and over (Rycroft 2012). COPD is a major cause of
morbidity and is the third most common cause of death globally
(Lozano 2012). People with COPD have abnormal respiratory
muscle function as a result of a mechanical disadvantage due to
lunghyperinflation, diaphragmatic dysfunction and asynchronous
breathing, and a reduction in respiratory muscle strength (Luce
1982). Symptoms of COPD include dyspnoea (breathlessness),
cough and fatigue. Postures that enhance the function of the di-
aphragm may assist with dyspnoea relief (Luce 1982). Reduced
functional capacity and physical inactivity are common features
(Troosters 2010; Singer 2011), which significantly increase the risk
for hospitalisation and mortality (Garcia-Aymerich 2006). Pul-
monary rehabilitation, encompassing exercise training, education
and behaviour change (Spruit 2013), is an important component
in the management of COPD and is beneficial in relieving dysp-
noea and fatigue, and improving health-related quality of life and
exercise capacity (McCarthy 2015).
Description of the intervention
Singing is the production of musical words or sounds with the
voice (Oxford 2016). Singing can be performed individually or
in a group (choir), and can be arranged or improvised. Singing
is a much more complex physical activity than speaking due to
the greater length of phrases and greater range of pitch required
(Irons 2010). Singing is dependent on the use of the lungs for air
supply. During normal tidal breathing, the diaphragm contracts
for inhalation, while exhalation occurs passively. During singing,
air flow must be regulated and larger lung volumes are required,
thus exhalation is active and aided by the abdominal, internal
intercostal and pelvic muscles. Singing requires a high degree of
muscle co-ordination by highly developed muscle reflexes. There
are four stages of breathing with singing: inhalation; suspension;
controlled exhalation (when phonation occurs); and recovery. A
singer controls these stages consciously until they become condi-
tioned reflexes (Mathis 2009).
Diaphragmatic breathing requires an increase in abdominal wall
motion with a reduction in upper rib cage motion (Gosselink
2004), and is the method of breathing employed by singers, as the
diaphragm can generate the greatest inspiratory muscle force to
increase lung volumes and change subglottal pressures necessary
for singing (Sundberg 1993). The subglottal air pressure require-
ments are much greater for singing tasks than for speaking tasks
(Leanderson 1987; Leanderson 1988), as higher subglottal pres-
sures are required for loudness and higher pitch (Sundberg 1993).
Audible speech can be produced with subglottal pressures as low
as 2 cmH2O (centimetre of water pressure), with ordinary speech
ranging from 7 cmH2O to 10 cmH2O; however, singing can vary
from 5 cmH2O to 40 cmH2O for soft to loud tones (Proctor
1980). An increase in subglottal pressure is achieved by decreasing
the volume of the rib cage using muscular forces, elasticity forces
and gravity (Sundberg 1993).
Posture can greatly affect the quantity of air, the capacity of the
lungs and the ability to move air in and out when singing. Good
posture facilitates an efficient breathing pattern and can influence
the voice (Bunch 1995; Staes 2011). Trained singers have greater
breathing efficiency and greater use of their lung capacity than
non-trained singers (Gould 1973; Salomoni 2016).
Mastery of diaphragmatic breathing is vital for singing. Data from
Engen 2005 suggests a minimum of four half-hour group singing
sessions could be sufficient for people with emphysema to learn
the diaphragmatic breathing technique correctly. Thus, singing
needs to be performed for a sufficient duration, and most likely
at a sufficient intensity in order to ensure an effective stimulus
for learning this technique and for potentially having an effect on
important health outcomes. The precise ’dosage’ will likely vary
for each person and may depend on their age, disease severity, and
previous experience with singing (Irons 2010).
How the intervention might work
Singing is an activity that has the potential to improve health
outcomes, such as relieving dyspnoea and enhancing quality of
life, in people with COPD due to employment of diaphragmatic
breathing, altered posture, and improved breathing co-ordination.
Qualitative studies of singing and health report that singing can
enhance mood, provide social support and friendship, help de-
velop self esteem and self confidence, relieve stress, promote good
posture and distract attention from personal worries (MacDonald
2012). Singing in people with COPDhas the potential to demon-
strate similar effects due to the enjoyable and low-risk nature of
the activity (Engen 2005), and may have a positive impact on the
distressing effects of COPD such as breathlessness, reduced qual-
ity of life and fatigue. The perceptions of people with COPD fol-
lowing a group singing programme support this (Morrison 2013;
Skingley 2014).
Therapies that incorporate breathing manoeuvres, such as con-
trolled breathing techniques including diaphragmatic breathing
and active expiration (as performed during singing), have been
shown to improve lung function (Esteve 1996), alleviate dyspnoea
and improve quality of life (Gosselink 2003; Gosselink 2004), and
improve functional exercise capacity (Holland 2012) in people
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withCOPD. Singing requires great control to ensure a smooth and
sustained exhalation. This exhalation is similar to that of pursed
lip breathing and controlled breathing, which have been shown
to reduce breathlessness in people with COPD (Gosselink 2003;
Bianchi 2004).
Education on breathing and air support is fundamental in the
process of learning to sing, and knowledge of the physical processes
that make up the act of singing, and how those processes function
(Mathis 2009), may improve breathing awareness and efficiency
in people with COPD.
Poor posture (hyperkyphosis), which is common in people with
COPD (Gaude 2014), can restrict the expansion of the rib cage
and movement of the diaphragm. Singing requires the develop-
ment of skills in controlling posture that may be transferable to
activities in daily life for people with COPD (Lord 2010).
Why it is important to do this review
Singing may have the potential to improve health outcomes in
people with COPD. Systematic reviews of research literature have
been completed for singing in other chronic respiratory diseases
such as bronchiectasis (Irons 2010), and cystic fibrosis (Irons
2016), and found an absence of randomised controlled trials
(RCTs) to support or refute the benefits of singing. However, the
authors of these reviews found studies that reported an improve-
ment in quality of life in people with COPD, and a systematic
review of singing for COPD has not yet been carried out. Fur-
thermore, whilst pulmonary rehabilitation improves physical and
psychosocial health outcomes in people with COPD (McCarthy
2015), the potential additional benefits of adding singing to pul-
monary rehabilitation has not been examined.
O B J E C T I V E S
To determine the effect of singing on health-related quality of life
and dyspnoea in people with COPD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) reported as full-
text, published as abstract only, and unpublished data. We used
data from studies published as abstract only where authors pro-
vided study data. Where the data were not available, we recorded
the studies as awaiting classification.
Types of participants
We included studies that involved adults with COPD, diagnosed
according to the investigators’ definition, of any age or disease
severity. The COPD was required to be stable (i.e. optimal and
stable respiratory medications with no exacerbation or hospitali-
sation within the previous month). We included participants with
COPD who used supplemental oxygen. Participants with and
without a history of singing training could be included, and we
recorded the singing training history wherever possible.
Types of interventions
We included studies examining structured, supervised singing
training of at least four weeks’ duration with a minimum of four
sessions. Studies were included that compared:
1. singing versus no intervention (usual care) or another
control intervention;
2. singing plus pulmonary rehabilitation versus pulmonary
rehabilitation alone.
The singing could be performed individually or as part of a group
(choir) facilitated by a singing leader, and inpatient and outpatient
programmes were included. In the case of interventions combin-
ing one or more components of music therapy, for example in-
strumental and singing training, the singing needed to form the
majority of the intervention. We recorded the precise nature of
the singing facilitators’ professional backgrounds, singing training
and any pulmonary rehabilitation programme (frequency, dura-
tion, type, intensity), wherever possible.
Types of outcome measures
Primary outcomes
1. Health-related quality of life, measured using total scores
from either generic or respiratory-specific quality-of-life
questionnaires.
2. Dyspnoea, measured using a dyspnoea scale (e.g. Medical
Research Council (MRC) dyspnoea scale (Bestall 1999)) or
dyspnoea scores from a respiratory-specific quality-of-life
questionnaire (e.g. dyspnoea domain of the Chronic Respiratory
Disease Questionnaire (Guyatt 1987)), or both.
Secondary outcomes
1. Respiratory muscle strength measured from a pressure
gauge (e.g. maximal inspiratory and expiratory mouth pressures
or maximal sniff nasal inspiratory pressure).
2. Pulmonary function measured by spirometry or
plethysmography (e.g. forced expiratory volume in one second
(FEV1) measured in litres or as per cent of predicted, forced vital
capacity (FVC), FEV1/FVC ratio, total lung capacity (TLC),
residual capacity (RC), functional residual capacity (FRC)).
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3. Psychological status measured from generic psychological
questionnaires or scales (e.g. Hospital Anxiety and Depression
Scale (Zigmond 1983)).
4. Functional exercise capacity measured from a functional
exercise test.
5. Peak exercise capacity measured from a peak exercise test.
6. Endurance exercise capacity measured from an endurance
exercise test.
7. Healthcare utilisation recorded as hospitalisation or length
of hospital stay, or both.
8. Physical activity level from objective measurement tools
(e.g. pedometers, accelerometers, multi-sensor devices).
9. Adverse events/side effects.
Reporting one or more of the outcomes listed here in the study
was not an inclusion criterion for the review. We reviewed primary
and secondary outcomes at baseline and immediately following
the intervention period. If outcomes were also measured in the
long term (e.g. six or 12 months after completion of intervention),
we reviewed each of these time points in addition to immediately
following the intervention period. The selected primary outcome
measures are important to patients and clinicians, and all outcome
measures were clinically relevant and could potentially be altered
by a singing intervention.
Search methods for identification of studies
Electronic searches
We identified trials from the Cochrane Airways Trials Register,
which is maintained by the Information Specialist for the group.
The Register contains studies identified from several sources:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL), through the Cochrane Register
of Studies Online (crso.cochrane.org);
2. weekly searches of MEDLINE Ovid SP 1946 to date;
3. weekly searches of Embase Ovid SP 1974 to date;
4. monthly searches of PsycINFO Ovid SP 1967 to date;
5. monthly searches of CINAHL EBSCO (Cumulative Index
to Nursing and Allied Health Literature) 1937 to date;
6. monthly searches of AMED EBSCO (Allied and
Complementary Medicine);
7. handsearches of the proceedings of major respiratory
conferences.
Studies contained in the Trials Register are identified through
search strategies based on the scope of Cochrane Airways. Details
of these strategies, as well as a list of handsearched conference pro-
ceedings are in Appendix 1. See Appendix 2 for search terms used
to identify studies for this review.
We also conducted a search of
ClinicalTrials.gov (www.ClinicalTrials.gov) and theWorld Health
Organization (WHO) trials portal (www.who.int/ictrp/en/) and
PEDro (www.pedro.org.au/). We searched all databases from their
inception to 1 August 2017, and we imposed no restriction on
language of publication.
Searching other resources
We checked reference lists of all primary studies and review ar-
ticles for additional references. We searched for errata or retrac-
tions from included studies published in full-text on PubMed (
www.ncbi.nlm.nih.gov/pubmed).
Data collection and analysis
Selection of studies
Two review authors (RJM, CE) independently screened titles and
abstracts of all the potential studies we identified as a result of the
search and coded them as ’retrieve’ (eligible or potentially eligible/
unclear) or ’do not retrieve’.We retrieved the full-text study reports
or publications and two review authors (RJM, CE) independently
screened the full text and identified studies for inclusion. They also
identified and recorded reasons for excluding ineligible studies.We
resolved any disagreement through discussion or we consulted a
third review author (ZJM). We identified and excluded duplicates
and collated multiple reports of the same study so that each study,
rather than each report, was the unit of interest in the review. We
recorded the selection process in sufficient detail to complete a
PRISMA flow diagram (Figure 1) and ’Characteristics of excluded
studies’ table (Moher 2009).
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Figure 1. Study flow diagram.
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Data extraction and management
We used a data collection form for study characteristics and out-
come data. One review author (RJM) extracted study character-
istics from included studies. A second review author (CE) spot-
checked study characteristics for accuracy against the trial report.
We extracted the following study characteristics:
1. methods: study design, total duration of study, details of
any ’run-in’ period, number of study centres and location, study
setting, withdrawals and date of study;
2. participants: number, mean age, age range, gender, severity
of condition, diagnostic criteria, baseline lung function, smoking
history, inclusion criteria and exclusion criteria;
3. interventions: intervention, comparison, concomitant
medications and excluded medications;
4. outcomes: primary and secondary outcomes specified and
collected, and time points reported;
5. notes: funding for trial and notable conflicts of interest of
trial authors.
Two review authors (RJM, CE) independently extracted outcome
data from included studies. One review author (RJM) transferred
data into ReviewManager 5 (RevMan 2014).We double-checked
that data were entered correctly by comparing the data presented
in the systematic review with the study reports.
Assessment of risk of bias in included studies
Two review authors (RJM, CE) independently assessed risk of bias
for each study using the criteria outlined in theCochraneHandbook
for Systematic Reviews of Interventions (Higgins 2011). We assessed
the risk of bias according to the following domains:
1. random sequence generation;
2. allocation concealment;
3. blinding of participants and personnel;
4. blinding of outcome assessment;
5. incomplete outcome data;
6. selective outcome reporting;
7. other bias.
We graded each potential source of bias as high, low or unclear and
provided a quote from the study report together with a justification
for our judgement in the ’Risk of bias’ table. We summarised the
’Risk of bias’ judgements across different studies for each of the
domains listed.
When considering treatment effects, we took into account the risk
of bias for the studies that contributed to that outcome.
Assessment of bias in conducting the systematic
review
We conducted this review according to the published protocol
(Differences between protocol and review).
Measures of treatment effect
We analysed continuous data as mean differences (MDs). We en-
tered data presented as a scale with a consistent direction of effect.
We undertook meta-analyses only where this was meaningful, that
is, if the treatments, participants and the underlying clinical ques-
tion were similar enough for pooling to make sense.
We narratively described skewed data reported as medians and
interquartile ranges.
Where multiple trial arms were reported in a single trial, we in-
cluded only the relevant arms. If two comparisons were combined
in the same meta-analysis, we halved the control group to avoid
double counting.
Unit of analysis issues
We did not include cross-over trials. If the search identified clus-
ter-randomised trials, the intention was to consult the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011),
however no cluster-randomised trials were identified.
Dealing with missing data
We contacted investigators in order to verify key study character-
istics and obtain missing numerical outcome data where possible
(e.g. when a study was identified as abstract only).
Assessment of heterogeneity
Weused the I2 statistic tomeasure heterogeneity among the studies
in each analysis. Heterogeneity was considered significant if the P
value was less than 0.10 (Higgins 2011).
Assessment of reporting biases
We were unable to pool more than 10 studies, however if more
studies are included in future review updates we will create and
examine a funnel plot to explore possible small-study and publi-
cation biases.
Data synthesis
We used a random-effects model using Review Manager 5
(RevMan 2014) and used change from baseline results to final
scores.
Where the outcomes were reported using adjusted analyses (such
as ANOVA or ANCOVA), we used the generic inverse variance
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method to combine the results with other studies; where adjusted
analyses were not available, we preferred change from baseline
results to final scores.
’Summary of findings’ table
We created a ’Summary of findings’ table using the following out-
comes: health-related quality of life and dyspnoea. We used the
five GRADE considerations (study limitations, consistency of ef-
fect, imprecision, indirectness and publication bias) to assess the
quality of the body of evidence as it related to the studies that
contributed data to the meta-analyses for the prespecified out-
comes. We used methods and recommendations described in Sec-
tion 8.5 and Chapter 12 of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011), and GRADEpro software
(GRADEpro GDT). We justified all decisions to downgrade or
upgrade the quality of studies using footnotes, and we have made
comments to aid the reader’s understanding of the review where
necessary.
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses if suffi-
cient studies were retrieved:
1. severity of lung disease - severe (FEV1 % predicted less than
40%) versus not severe (FEV1 % predicted 40% predicted or
greater);
2. mode of singing intervention - individual versus group
(choir);
3. participant’s experience with singing training - no previous
history with singing training versus prior history of singing
training;
4. singing facilitator’s professional background - formally
trained music or singing professional versus health or lay
professional.
We planned to use the following outcomes in subgroup analyses:
1. health-related quality of life;
2. dyspnoea.
We were unable to perform subgroup analyses due to the small
number of studies. Ifmore studies are included in future updates of
this review,wewill perform subgroup analyses using the formal test
for subgroup interactions in Review Manager 5 (RevMan 2014).
Sensitivity analysis
We planned to carry out the following sensitivity analysis:
1. studies with a low risk of bias (to examine the effects of
removing studies with a high risk of bias).
We were unable to conduct this sensitivity analysis because of the
small number of studies. If more studies are included in future
review updates, a sensitivity analysis will be performed to analyse
the effects of studies with a low risk of bias for at least three of
the following domains: random sequence generation, allocation
concealment, blinding of outcome assessment, and incomplete
outcome data.
R E S U L T S
Description of studies
Refer to the Characteristics of included studies, Characteristics
of excluded studies and Characteristics of studies awaiting
classification for the details of the studies included, excluded and
awaiting classification.
Results of the search
Our search of the databases identified 50 citations. We identified
three additional citations through handsearching. After removing
duplicates, we reviewed 49 citation titles and abstracts, of which
we excluded 38. We screened the full-text versions of eleven cita-
tions for eligibility, and excluded two because they did not meet
the review inclusion criteria. Nine citations were appropriate for
inclusion in the review, however one citation was published in
abstract form only and our attempts to contact the authors were
unsuccessful. This study remains as a study awaiting classification.
The remaining eight citations represented three studies. We cre-
ated aPRISMAflowdiagram todepict the search results (Figure 1).
The review authors agreed on the inclusion of all citations, with a
Cohen’s kappa measurement of 1, indicating excellent agreement.
Included studies
We identified three studies (a total of 112 participants) which met
the inclusion criteria for this review. They were represented by
eight citations which were reviewed in full-text. The full details
of these studies can be found in the Characteristics of included
studies table.
The sample size of studies ranged from 33 to 43 participants. All
studies included participants diagnosed with chronic obstructive
pulmonary disease (COPD), with a mean age ranging from 67
to 72 years and a mean forced expiratory volume in one second
(FEV1) ranging from 37% to 64% of predicted values.
All studies randomised participants to a singing group or another
control intervention. The frequency of the singing intervention
in the studies ranged from 1 to 2 times a week over a 6 to 24
week period. The duration of the singing sessions was 60 min-
utes and they were conducted in groups led by a singing teacher.
The singing sessions were structured in nature and included re-
laxation exercises, breathing exercises, vocalisation exercises, and
singing. All studies began with relaxation exercises of the neck
and upper limb muscles, or postural work and physical stretches.
One study had participants perform singing-related breathing ex-
ercises consisting of fast, deep inspirations, followed by slow, full
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or interrupted expirations; performing fast and deep respiratory
incursions, paying attention to the upper abdominal movements;
and generating breathing movements against, or with the help
of, pressures generated by a hand placed on the upper abdominal
region (Bonilha 2009). All studies performed vocal exercises, for
example, pronouncing vowels such as “le”, “la”, “mi”, “mu”, and
singing the melody of a familiar song using such vowels instead of
actually singing the lyrics (Bonilha 2009). In all the studies, par-
ticipants sang songs for 20 to 30 minutes. The comparison groups
included a film workshop (Lord 2012), handcraft work (Bonilha
2009), and no intervention (Lord 2010).
The primary outcome of health-related quality of life was mea-
sured in all three studies, using the St George’s Respiratory Ques-
tionnaire total score (Bonilha 2009; Lord 2010), the SF-36 Phys-
ical Component Summary (PCS) and Mental Component Sum-
mary (MCS) scores (Lord 2010; Lord 2012), and the COPD As-
sessment Test (CAT) total score (Lord 2012). The primary out-
come of dyspnoea was assessed in one study using the Basal Dys-
pnea Index (BDI) (Bonilha 2009).
The following secondary outcomes weremeasured by the included
studies: respiratory muscle strength (Bonilha 2009); pulmonary
function (Bonilha 2009); psychological status (Lord 2010; Lord
2012); peak exercise capacity (Lord 2010; Lord 2012); and phys-
ical activity level (Lord 2012).
The following secondary outcomes were not measured by the in-
cluded studies: functional exercise capacity; endurance exercise ca-
pacity; and healthcare utilisation.
Excluded studies
We excluded two citations (representing one study) from this re-
view due to the intervention not meeting the inclusion criteria.
Risk of bias in included studies
Our assessment of the risk of bias in the included studies is pre-
sented in Figure 2 and Figure 3.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
All three studies reported participant randomisation, however one
study did not provide sufficient information to determine the se-
quence generation or allocation concealment (Bonilha 2009).
Blinding
Blinding of personnel and participants was not possible due to the
physical nature of the intervention. Two studies reported blinding
of the outcome assessor (Lord 2010; Lord 2012).
Incomplete outcome data
All three studies reported dropouts and loss to follow-up ranging
from 22% to 30% (Bonilha 2009; Lord 2010; Lord 2012).
Selective reporting
Two studies reported all outcome measures as prespecified in the
methods (Bonilha 2009; Lord 2010). One study did not report
all outcomes at the post intervention time point as prespecified in
the methods (Lord 2012).
Other potential sources of bias
All three studies appeared to be free of other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison
See Summary of findings for the main comparison.
The Data and analyses table summarises the results of the meta-
analyses for the comparison of singing to a control group. All three
studies reported the results as change from baseline measures.
Primary outcomes
Health-related quality of life
Two studies reported results which could be pooled for meta-
analysis for the St George’s Respiratory Questionnaire (Bonilha
2009; Lord 2010). Results of themeta-analysis are shown in Figure
4. There was no statistically significant improvement in the St
George’s Respiratory Questionnaire total score (mean difference
(MD) -0.82, 95% confidence interval (CI) -4.67 to 3.02, n =
58). We assessed the quality of the evidence as low according to
GRADE criteria (Summary of findings for the main comparison).
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Figure 4. Forest plot of comparison: 1 Intervention - Singing vs Control, outcome: 1.1 Health-related
quality of life - respiratory specific (mean change).
Two studies reported results which could be pooled for meta-
analysis for the SF-36 (Lord 2010; Lord 2012). Results of themeta-
analysis are shown in Figure 5. There was a statistically significant
improvement in the SF-36 Physical Component Summary (PCS)
score favouring the singing group (MD 12.64, 95% CI 5.50 to
19.77, n = 52). There was no statistically significant improvement
in the SF-36 Mental Component Summary (MCS) score, but the
confidence interval is wide (MD 5.42, 95% CI -3.90 to 14.74, n
= 52). We assessed the quality of the evidence as low according to
GRADE criteria (Summary of findings for the main comparison).
Figure 5. Forest plot of comparison: 1 Intervention - Singing vs Control, outcome: 1.2 Health-related
quality of life - generic (mean change).
Dyspnoea
Only one study (Bonilha 2009) reported results for dyspnoea
(Figure 6). The mean improvement in the Basal Dyspnoea Index
(BDI) score favouring the singing group was not statistically sig-
nificant (MD0.40, 95%CI -0.65 to 1.45, n = 30).We assessed the
quality of the evidence as very low according to GRADE criteria
(Summary of findings for the main comparison).
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Figure 6. Forest plot of comparison: 1 Intervention - Singing vs Control, outcome: 1.3 Dyspnoea (mean
change).
Secondary outcomes
Respiratory muscle strength
One study reported measures of respiratory muscle strength
(Bonilha 2009). There was an improvement in maximal inspira-
tory pressure (PImax, cmH2O) favouring singing, but the confi-
dence interval is too wide to exclude a possible reduction in inspi-
ratory muscle pressure with the intervention (MD 4.00, 95% CI
-8.49 to 16.49, n = 30).
There was a statistically significant improvement in maximal ex-
piratory pressure (PEmax, cmH2O) favouring the singing group
(MD 14.30, 95% CI 0.87 to 27.73, n = 30).
Pulmonary function
One study (Bonilha 2009) reported measures of pulmonary func-
tion in 30 participants, including forced expiratory volume in one
second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, end
respiratory volume (ERV), and inspiratory capacity (IC). There
were no statistically significant differences between the singing
group and control group for any of these measures (FEV1 litres
(L) MD -0.03, 95% CI -0.20 to 0.14; FVC (L) MD -0.04, 95%
CI -0.33 to 0.25; FEV1/FVC (%) MD 0.40, 95% CI -4.05 to
4.85; ERV (L) MD 0.17, 95% CI -0.06 to 0.40; IC (L) MD -
0.16, 95% CI -0.37 to 0.05).
Psychological status
Two studies reported results which could be pooled for meta-
analysis for the Hospital Anxiety and Depression Scale (HADS)
(Lord 2010; Lord 2012). There was no statistically significant
improvement in the HADS anxiety score (MD -1.09, 95% CI -
3.02 to 0.83, n = 52) or HADS depression score (MD -0.87, 95%
CI -2.16 to 0.42, n = 52).
Functional exercise capacity
No studies measured functional exercise capacity.
Peak exercise capacity
Two studies reported results which could be pooled for meta-
analysis using the Incremental Shuttle Walk Test (ISWT) (Lord
2010; Lord 2012). There is uncertainty due to imprecision about
whether singing has an impact on ISWT distance (metres) com-
pared to control (MD -9.26, 95% CI -43.10 to 24.57, n = 52).
Endurance exercise capacity
No studies measured endurance exercise capacity.
Healthcare utilisation
No studies measured healthcare utilisation or hospitalisation.
Physical activity level
One study (Lord 2012) reported measures of physical activity for
24 participants, including steps (steps per day), sedentary time
(minutes per day), physical activity duration (minutes per day),
and active energy expenditure (kJ per day). There were no statisti-
cally significant differences between the singing group and control
group for sedentary time (minutes per day), but the confidence
interval is wide (MD -8.60, 95% CI -88.33 to 71.13). There were
statistically significant differences in the remaining measures of
physical activity favouring the control group (steps (steps per day)
MD -1774.00, 95% CI -2847.73 to -700.27; physical activity
duration (minutes per day) MD -142.20, 95% CI -262.56 to -
21.84; active energy expenditure (kJ per day) MD -373.00, 95%
CI -625.28 to -120.72).
Adverse events and side effects
No adverse events or side effects were reported by any of the in-
cluded studies, and participant withdrawal reasons (where pro-
vided) were unrelated to the singing intervention. The study by
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Bonilha 2009 reported that the vocal exercises and singing was
well tolerated by the participants, with no complaints of severe
dyspnoea, chest pain, regurgitation or dizziness (Bonilha 2009).
In the study by Lord 2010, no participants reported any negative
effects from the singing (Lord 2010). Lord 2012 did not report
on this outcome (Lord 2012).
D I S C U S S I O N
Summary of main results
We included three studies with a total of 112 participants in this
review. The sample size of studies ranged from 33 to 43 partic-
ipants. All studies included participants diagnosed with chronic
obstructive pulmonary disease (COPD) with a mean age ranging
from 67 to 72 years and mean forced expiratory volume in one
second (FEV1) ranging from 37% to 64% of predicted values. All
studies randomised participants to a singing or a control group.
The comparison groups included a film workshop (Lord 2012),
handcraft work (Bonilha 2009), and no intervention (Lord 2010).
The frequency of the singing intervention in the studies ranged
from 1 to 2 times a week over a 6 to 24 week period. The duration
of the singing sessions was 60 minutes.
Results for health-related quality of life were diverse. There was
no significant change in the St George’s Respiratory Question-
naire total score between groups, however a statistically significant
improvement in the SF-36 Physical Component Summary (PCS)
score favouring the singing group was found (MD 12.64, 95%
CI 5.50 to 19.77, 2 studies, n = 52) which surpassed the minimal
important difference of 4 units (Hays 2001). No change in dysp-
noea was demonstrated.
Measures of pulmonary function and inspiratory muscle strength
were only measured in one study and showed no significant dif-
ferences between the singing group and control group. There was
a statistically significant improvement in expiratory muscle pres-
sure favouring the singing group, although this improvement was
not clinically significant. No improvement in anxiety, depression,
exercise capacity or physical activity level following singing were
found. Healthcare utilisation was not measured by any studies and
no adverse effects from singing were reported. There are no data to
draw conclusions about the long-term effects of singing in people
with COPD.
The main results show few statistically or clinically significant
health outcomes. There were baseline imbalances between the
studies, especially in lung function. This, along with the small
number of participants, may have affected the precision around
the mean differences. There is a clear need for larger trials with
longer duration of follow-up to gain a better understanding of the
effects of singing in people with COPD.
Overall completeness and applicability of
evidence
Applicability of evidence includes consideration of whether peo-
ple with COPD would be willing or motivated to participate in
singing. Participants in the included studies were recruited from
hospital respiratory clinics and no information was provided on
previous experience of COPD management, such as pulmonary
rehabilitation, or indeed of singing. A recent qualitative study
found that people with COPD perceive that pulmonary rehabil-
itation does not fit their perception of health and that partici-
pation may be time-consuming and conflict with daily activities
(Mathar 2017). It is not known whether singing might be con-
sidered similarly and what the impact of this might be on recruit-
ment to a randomised controlled trial. Nonetheless, qualitative re-
search studies have reported high satisfaction with singing by peo-
ple with COPD, including self-reported improvements in both
breathing and psychological outcomes (Goodridge 2013; Pacheco
2014; McNaughton 2016).
This review included people with stable COPD of moderate to
severe disease severity, therefore the results cannot be extrapolated
to people with unstable disease such as during or following an
exacerbation, or to people with milder COPD. The studies also
only reported the short-term effects of singing.Without long-term
studies, the effect of singing over a longer period of time cannot
be determined. Furthermore, no healthcare utilisation data was
reported in any of the selected studies which is particularly impor-
tant in relation to commissioning and potential for incorporation
of findings into healthcare guidelines in the future.
Two studies randomised participants to an active comparison
group which matched the time and attention of the singing group.
However, the comparison group of one study provided no inter-
vention. With an insufficient number of trials randomising par-
ticipants to active and non-active comparison groups, we cannot
determine whether any improvements in health outcomes were
simply a result of participation in a group with support from a
leader and fellow participants.
From the data in this review, we cannot determine the optimal
delivery mode or dosage of singing required to achieve positive
health outcomes in people with COPD. The singing in each study
was delivered by a singing teacher, however all studies delivered
the singing in groups, so the effect of individual singing lessons in
people with COPD cannot be ascertained. The frequency and du-
ration of the singing programs ranged from once to twice a week,
and from 6 to 24 weeks in length. It is unclear what frequency and
duration is sufficient to provide an effective stimulus for learn-
ing the technique of singing and to have an effect on our health
outcomes of interest. In all studies participants were instructed
to practice their singing at home, however compliance was not
measured, therefore it is unknown whether more frequent singing
than the supervised group sessions may have contributed to some
of the outcomes.
There was general consistency in direction of effects in most out-
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comes. However, the outcome of anxiety showed an opposite ef-
fect. The results from Lord 2010 favoured singing, whilst Lord
2012 results favoured the control group. This inconsistency may
be explained by the clinical heterogeneity of the two trials with
baseline differences in lung function, anxiety, quality of life and
exercise capacity, or it may simply be explained by the impact of
chance on such small numbers of participants in each group.
Whilst there was one clinically significant result for singing
demonstrating an improvement in the SF-36 PCS score, the di-
versity in results for health-related quality of life may be explained
by the methods employed by the studies. A primary outcome and
sample size calculation was only reported by one of the included
studies (Lord 2012). Therefore, we cannot determine whether two
of the three included studies had an adequate sample size calcula-
tion or were adequately powered to determine a significant change
for the outcome of health-related quality of life. There was a clin-
ically significant change in physical activity favouring the control
group in one study (Lord 2012) which is difficult to explain. No
other health outcome was clinically significant, although the im-
provement in anxiety following singing showed a trend towards
the minimal important difference (Puhan 2008). The small num-
ber of studies and small sample sizes are most likely the major rea-
sons why the changes in outcomes in this review were so variable.
Quality of the evidence
The overall quality of the evidence for the studies included in this
review was very low to low. The major methodological shortcom-
ing was the small sample size of the studies. The quality of the
evidence was also impacted by the inability to blind the popula-
tion and personnel due to the physical nature of the intervention.
An unknown randomisation process and lack of blinding of the
outcome assessor compromised the quality of one study (Bonilha
2009), whilst a reporting bias was present in another study (Lord
2012).
Potential biases in the review process
We adhered to the standard Cochrane methodological procedures
to minimise bias, including having two authors independently
screen trials, extract trial data and perform the ’Risk of bias’ assess-
ment. Attempts were made to contact trial authors where missing
information was identified and for a study published in abstract
form only, however data were not provided.
Agreements and disagreements with other
studies or reviews
This findings of this Cochrane review are consistent with the over-
all findings of a recent review of singing for lung health in people
with COPD (Lewis 2016). Cohort and qualitative data were also
examined as part of the narrative literature review which found
that participants generally reported positive impacts of singing
on their activities of daily living such as housework, their ability
to manage their breathlessness, and improved well-being (Lewis
2016). These findings are in agreement with the positive effects
shown in this review for one aspect of health-related quality of
life, even though the results of the meta-analyses with this small
population did not demonstrate clinical significance for all health-
related quality of life measures.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is limited low-quality evidence that singing is safe for people
with moderate to severe COPD and improves physical health (as
measured by the SF-36 physical component score). Whilst singing
may be appealing and subjectively beneficial to some people with
COPD, there is currently insufficient evidence to advocate singing
as an effective intervention to achieve clinically significant health
outcomes above and beyond no intervention or group-based recre-
ational activities.
Implications for research
More randomised controlled trials are required to determine the
effect of singing on health-related quality of life and dyspnoea
in people with COPD; trials examining the effect of singing in
addition topulmonary rehabilitation are also needed. In particular,
large studieswith long-term follow-up are necessary. Future studies
need to incorporate important methodological features such as
adequate sample sizes, randomisation, allocation concealment and
blinding of outcome assessors, aswell as longer follow-up, to ensure
high-quality evidence is available on the effectiveness of singing in
people with COPD.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bonilha 2009
Methods Study design: randomised controlled trial
Participants Participants: n = 43
Included: COPD (according to GOLD criteria); stable for 2 months; ex-smoker
Excluded: severe comorbidities; oxygen therapy; smoker
Baseline characteristics:
Intervention group - singing (n = 15)
1. Gender, male: n = 12
2. Age, years: mean (SD) 70 (7)
3. FEV1, L: 1.11 (0.47)
4. FEV1, % predicted: 49 (21)
5. FEV1/FVC, %: 46 (18)
Control group - handcraft (n = 15)
1. Gender, male: n = 12
2. Age, years: 74 (8)
3. FEV1, L: 1.18 (0.47)
4. FEV1, % predicted: 53 (20)
5. FEV1/FVC, %: 43 (11)
Interventions Intervention characteristics:
Intervention group - singing
1. Duration (session): 1 hour
2. Frequency: 1/week
3. Length (programme): 24 weeks
4. Professional/s: physiotherapist + singing teacher
5. Location: not reported
6. Session details: (1) relaxation exercises of neck and upper limb muscles, conducted
by a physiotherapist (5 minutes); (2) singing-related respiratory exercises conducted by
a singing teacher (10 minutes) - these exercises are part of regular singing teaching, and
consisted of: performing fast, deep inspirations, followed by slow, full or interrupted
expirations; performing fast and deep respiratory incursions, paying attention to the
upper abdominal movements; generating breathing movements against, or with the
help, of pressures generated by a hand placed on the upper abdominal region; (3)
vocalisation exercises, lead by the singing teacher, as a preparation for singing (15
minutes) - participants loudly pronounced vowels such as “le”, “la”, “mi”, “mu”, and
also sang the melody of a familiar song using such vowels instead of actually singing the
lyrics; (iv) singing training of Brazilian folk songs, conducted by the singer teacher (30
minutes)
7. Additional information: participants were also instructed to practice the folk songs
at home for half an hour on at least two more days during the week
Control group - handcraft
1. Duration (session): 55 minutes
2. Frequency: 1/week
3. Length (programme): 24 weeks
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Bonilha 2009 (Continued)
4. Professional/s: physiotherapist + handcraft work teacher
5. Session details: (I) relaxation exercises of neck and upper limb muscles, conducted
by a physiotherapist (5 minutes); (ii) execution of handcraft artwork such as paper
folding, drawing, and collages (50 minutes)
6. Additional information: participants were also routinely instructed to include
some incomplete artwork or beginning a new one at home
Outcomes Health-related quality of life - St George’s Respiratory Questionnaire, total score
1. Outcome type: continuous outcome
2. Range: 0-100
3. Unit of measure: percent, %
4. Direction: lower is better
5. Data value: change from baseline
Dyspnoea - Basal Dyspnoea Index (BDI), score
1. Outcome type: continuous outcome
2. Range: 0-12
3. Unit of measure: score
4. Direction: higher is better
5. Data value: change from baseline
Respiratory muscle strength - PImax, cmH2O
1. Outcome type: continuous outcome
2. Unit of measure: cmH2O
3. Direction: higher is better
4. Data value: change from baseline
Respiratory muscle strength - PEmax, cmH2O
1. Outcome type: continuous outcome
2. Unit of measure: cmH2O
3. Direction: higher is better
4. Data value: change from baseline
Lung function - FVC, L
1. Outcome type: continuous outcome
2. Unit of measure: litre, L
3. Direction: higher is better
4. Data value: change from baseline
Lung function - FEV1, L
1. Outcome type: continuous outcome
2. Unit of measure: litre, L
3. Direction: higher is better
4. Data value: change from baseline
Lung function - FEV1/FVC, %
1. Outcome type: continuous outcome
2. Unit of measure: percent, %
3. Direction: higher is better
4. Data value: change from baseline
Lung function - ERV, L
1. Outcome type: continuous outcome
2. Unit of measure: L
3. Direction: higher is better
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Bonilha 2009 (Continued)
4. Data value: change from baseline
Lung function - IC, L
1. Outcome type: continuous outcome
2. Unit of measure: litre, L
3. Direction: higher is better
4. Data value: change from baseline
Identification Country: Brazil
Setting: hospital
Authors name: Amanda Gimenes Bonilha
Institution: University of Sao Paulo
Email: jabmarti@fmrp.usp.br
Address: InternalMedicine Department, Avenida Bandeirantes 3900, CEP: 14048-800,
Ribeirao Preto, Sao Paulo, Brazil
Notes Authors were contacted for further information, with no response.
Sponsorship source: Not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not specified
Allocation concealment (selection bias) Unclear risk Not specified
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not specified, but due to the physical na-
ture of the intervention it is unlikely the
participants were able to be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes measured reported for all par-
ticipants completing post intervention as-
sessment
High dropout rate from singing group
(35%)
Selective reporting (reporting bias) Low risk All outcome measures listed in methods
were reported
Other bias Low risk Study appears to be free of other sources of
bias
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Lord 2010
Methods Study design: randomised controlled trial
Participants Participants: n = 36
Included: COPD (diagnosed according to the GOLD guidelines and attending respi-
ratory clinics)
Baseline characteristics
Intervention group - singing (n = 15)
1. Gender: not reported
2. Age, years: mean (SD) 67 (9)
3. FEV1, % predicted: 37 (15)
4. Long-term oxygen therapy, n (%): 4 (27)
Control group - no intervention (n = 13)
1. Gender: not reported
2. Age, years: 68 (7)
3. FEV1, % predicted: 38 (22)
4. Long-term oxygen therapy, n (%): 4 (31)
Interventions Intervention characteristics:
Intervention group - singing
1. Duration (session): 1 hour
2. Frequency: 2/week
3. Length (program): 6 weeks
4. Professional/s: singing teacher
5. Location: hospital
6. Session details: 20 minutes - postural work and physical stretches; 10 minutes -
breath observation and management/relaxation; 10 minutes - vocal exercises; 10-20
minutes - singing songs
7. Additional information: each participant was given homework and an
accompanying CD of songs to practice at home
Control group - no intervention
Outcomes Health-related quality of life - SF-36 Physical Component Summary (PCS), score
1. Outcome type: continuous outcome
2. Range: 0-100
3. Unit of measure: score
4. Direction: higher is better
5. Data value: change from baseline
Quality of life - SF-36 Mental Component Summary (MCS), score
1. Outcome type: continuous outcome
2. Range: 0-100
3. Unit of measure: score
4. Direction: higher is better
5. Data value: change from baseline
Psychological status - Hospital Anxiety and Depression Scale (HADS) - anxiety subscale, score
1. Outcome type: continuous outcome
2. Range: 0-21
3. Unit of measure: score
4. Direction: lower is better
5. Data value: change from baseline
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Lord 2010 (Continued)
Psychological status - Hospital Anxiety and Depression Scale (HADS) - depression subscale,
score
1. Outcome type: continuous outcome
2. Range: 0-21
3. Unit of measure: score
4. Direction: lower is better
5. Data value: change from baseline
Peak exercise capacity - Incremental Shuttle Walk Test (ISWT), m
1. Outcome type: continuous outcome
2. Unit of measure: metres, m
3. Direction: higher is better
4. Data value: change from baseline
Identification Country: United Kingdom
Setting: hospital
Authors name: Victoria M Lord
Institution: Royal Brompton & Harefield NHS Foundation Trust
Email: n.hopkinson@imperial.ac.uk
Address: Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Notes Prior to randomisation, all study participants received a 30-minute standard session on
breathing control and techniques to manage breathlessness, delivered by a respiratory
physiotherapist. Pursed lip breathing and nose breathing were also discussed in relation
to managing episodes of shortness of breath. Each participant received a standard Royal
Brompton Hospital “Help Yourself - physiotherapy for people with respiratory symp-
toms” and was advised to practice the techniques at home
Sponsorship source: Royal Brompton and Harefeld Arts (rb&hArts)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomisation
Allocation concealment (selection bias) Low risk Consecutive sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not specified, but due to the physical na-
ture of the intervention it is unlikely the
participants were able to be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blinded to treatment alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes measured reported for all par-
ticipants completing post intervention as-
sessment
High dropout rate from singing group
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Lord 2010 (Continued)
(25%)
Selective reporting (reporting bias) Low risk All outcome measures listed in methods
were reported
Other bias Low risk Study appears to be free of other sources of
bias
Lord 2012
Methods Study design: randomised controlled trial
Participants Participants: n = 33
Included: COPD (diagnosed according to the GOLD guidelines and attending respi-
ratory clinics)
Baseline characteristics:
Intervention group - singing (n = 18)
1. Gender: not reported
2. Age, years: mean (SD) 69 (11)
3. FEV1, % predicted: 44 (14)
Control group - film workshop (n = 15)
1. Gender: not reported
2. Age, years: 68 (9)
3. FEV1, % predicted: 64 (26)
Interventions Intervention characteristics:
Intervention group - singing
1. Duration (session): 1 hour
2. Frequency: 2/week
3. Length (program): 8 weeks
4. Professional/s: singing teacher
5. Location: not reported
6. Session details: 20 minutes - postural work and physical stretches; 10 minutes -
breath observation and management/relaxation; 10 minutes - vocal exercises; 10-20
minutes - singing songs
7. Additional information: participants were given a CD of physical warm-ups,
breathing exercises and songs to practice at home daily
Control group - film workshop
1. Duration (session): duration of film (variable) + 1 hour
2. Frequency: 1/week
3. Length (program): 8 weeks
4. Professional/s: film studies graduate
5. Session details: watched a film in a group and discussed salient points in the
workshop afterwards
Outcomes Health-related quality of life - SF-36 Physical Component Summar (PCS), score
1. Outcome type: continuous outcome
2. Range: 0-100
3. Unit of measure: score
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Lord 2012 (Continued)
4. Direction: higher is better
5. Data value: change from baseline
Health-related quality of life - SF-36 Mental Component Summary (MCS), score
1. Outcome type: continuous outcome
2. Range: 0-100
3. Unit of measure: score
4. Direction: higher is better
5. Data value: change from baseline
Health-related quality of life - COPD Assessment Test (CAT), score
1. Outcome type: continuous outcome
2. Range: 0-40
3. Unit of measure: score
4. Direction: lower is better
5. Data value: change from baseline
Psychological status - Hospital Anxiety and Depression Scale (HADS) - anxiety subscale, score
1. Outcome type: continuous outcome
2. Range: 0-21
3. Unit of measure: score
4. Direction: lower is better
5. Data value: change from baseline
Psychological status - Hospital Anxiety and Depression Scale (HADS) - depression subscale,
score
1. Outcome type: continuous outcome
2. Range: 0-21
3. Unit of measure: score
4. Direction: lower is better
5. Data value: change from baseline
Peak exercise capacity - Incremental Shuttle Walk Test (ISWT), m
1. Outcome type: continuous outcome
2. Unit of measure: metres, m
3. Direction: higher is better
4. Data value: change from baseline
Physical activity - steps per day, n
1. Outcome type: continuous outcome
2. Unit of measure: number, n
3. Direction: higher is better
4. Data value: change from baseline
Physical activity - sedentary time per day, min
1. Outcome type: continuous outcome
2. Unit of measure: min
3. Direction: lower is better
4. Data value: change from baseline
Physical activity - physical activity duration per day, min
1. Outcome type: continuous outcome
2. Unit of measure: minute, min
3. Direction: higher is better
4. Data value: change from baseline
Physical activity - active energy expenditure per day, kJ
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Lord 2012 (Continued)
1. Outcome type: continuous outcome
2. Unit of measure: kilojoule, kJ
3. Direction: higher is better
4. Data value: change from baseline
Identification Country: United Kingdom
Setting: hospital
Authors name: Victoria M Lord
Institution: Royal Brompton & Harefield NHS Foundation Trust
Email: n.hopkinson@ic.ac.uk
Address: Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Notes Prior to randomisation, all study participants received a 30-minute standard session on
breathing control and techniques to manage breathlessness, delivered by a respiratory
physiotherapist. Pursed-lip breathing and nose breathing were also discussed in relation
to managing episodes of shortness of breath. Each participant received a standard Royal
Brompton Hospital “Help Yourself - physiotherapy for people with respiratory symp-
toms” and was advised to practice the techniques at home
Sponsorship source: Royal Brompton and Harefield Arts (rb&hArts)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The sequence was developed by an author
who was not involved with the day to day
conduct of the trial
Allocation concealment (selection bias) Low risk Consecutive sequentially numbered sealed
envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not specified, but due to the physical na-
ture of the intervention it is unlikely the
participants were able to be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blinded to treatment alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes measured reported for all par-
ticipants completing post intervention as-
sessment
High dropout rate from singing group
(28%)
Selective reporting (reporting bias) High risk Spirometry and exacerbation rate were not
reported post intervention
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Lord 2012 (Continued)
Other bias Low risk Study appears to be free of other sources of
bias
cmH2O: centimetre of water
COPD: chronic obstructive pulmonary disease
ERV: end respiratory volume
FEV1: forced expiratory volume in one second
FVC: forced vital capacity
GOLD: Global Initiative for Chronic Obstructive Lung Disease
IC: inspiratory capacity
L: litre
min: minute
PImax: maximal inspiratory pressure
PEmax: maximal expiratory pressure
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Canga 2015 Intervention did not meet study inclusion criteria of singing forming the majority of the intervention
Characteristics of studies awaiting assessment [ordered by study ID]
Miyahara 2001
Methods Study design: randomised controlled trial
Participants Participants: n = 20
Included: COPD (moderate to severe)
Baseline characteristics:
1. Gender: not reported
2. Age, years: not reported
3. FEV1, % predicted: mean (SD) 40 (15)
Interventions Intervention characteristics:
Intervention group - Japanese traditional “Shigin” singing programme
1. Duration (session): not reported
2. Frequency: 5/week
3. Length (program): 8 weeks
4. Professional/s: not reported
5. Session details: the Japanese traditional “Shigin” signing program requires slow and deep breaths during singing
6. Intensity: dyspnoea score of 3-5 (on BORG scale 0-10)
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Miyahara 2001 (Continued)
Control group - no training
Outcomes Pulmonary function
Respiratory muscle strength
Peak exercise capacity
Health-related quality of life - Chronic Respiratory Disease Questionnaire, score
Notes Abstract only
Authors were contacted for further information, with no response
COPD: chronic obstructive pulmonary disease
FEV1: forced expiratory volume in one second
Characteristics of ongoing studies [ordered by study ID]
Kaasgaard 2017
Trial name or title The effects of singing training for patients with chronic obstructive pulmonary disease
Methods Cluster-randomised controlled trial
Participants People with COPD
Interventions Singing group versus pulmonary rehabilitation group; 90 minute sessions twice weekly for 10 weeks
Outcomes Not known
Starting date Not known
Contact information Mette Kaasgaard (mk@clin.au.dk)
Notes Researcher was contacted for further information, with no response
COPD: chronic obstructive pulmonary disease
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention - Singing vs Control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Health-related quality of life
- respiratory specific (mean
change)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 St George’s Respiratory
Questionnaire (total score)
2 58 Mean Difference (IV, Random, 95% CI) -0.82 [-4.67, 3.02]
2 Health-related quality of life -
generic (mean change)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 SF-36 PCS score 2 52 Mean Difference (IV, Random, 95% CI) 12.64 [5.50, 19.77]
2.2 SF-36 MCS score 2 52 Mean Difference (IV, Random, 95% CI) 5.42 [-3.90, 14.74]
3 Dyspnoea (mean change) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
3.1 BDI (score) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4 Respiratory muscle strength
(mean change)
1 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 PImax (cmH2O) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 PEmax (cmH2O) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Pulmonary function (mean
change)
1 Mean Difference (IV, Random, 95% CI) Totals not selected
5.1 FEV1 (L) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.2 FVC (L) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.3 FEV1/FVC (%) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.4 ERV (L) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.5 IC (L) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6 Psychological status (mean
change)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 HADS - anxiety score 2 52 Mean Difference (IV, Random, 95% CI) -1.09 [-3.02, 0.83]
6.2 HADS - depression score 2 52 Mean Difference (IV, Random, 95% CI) -0.87 [-2.16, 0.42]
7 Peak exercise capacity (mean
change)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
7.1 ISWT - metres 2 52 Mean Difference (IV, Random, 95% CI) -9.26 [-43.10, 24.
57]
8 Physical activity level (mean
change)
1 Mean Difference (IV, Random, 95% CI) Totals not selected
8.1 Sedentary time (minutes
per day)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
8.2 Steps (steps per day) 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
8.3 Physical activity duration
(minutes per day)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
8.4 Active energy expenditure
(kJ per day)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Intervention - Singing vs Control, Outcome 1 Health-related quality of life -
respiratory specific (mean change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 1 Health-related quality of life - respiratory specific (mean change)
Study or subgroup Singing Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 St George’s Respiratory Questionnaire (total score)
Bonilha 2009 15 -5.9 (5.8) 15 -5 (7.8) 61.1 % -0.90 [ -5.82, 4.02 ]
Lord 2010 15 -1.1 (10.6) 13 -0.4 (5.6) 38.9 % -0.70 [ -6.87, 5.47 ]
Subtotal (95% CI) 30 28 100.0 % -0.82 [ -4.67, 3.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.2. Comparison 1 Intervention - Singing vs Control, Outcome 2 Health-related quality of life -
generic (mean change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 2 Health-related quality of life - generic (mean change)
Study or subgroup Singing Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 SF-36 PCS score
Lord 2010 15 7.5 (14.6) 13 -3.8 (8.4) 67.4 % 11.30 [ 2.61, 19.99 ]
Lord 2012 13 12.9 (19) 11 -2.5 (11.9) 32.6 % 15.40 [ 2.90, 27.90 ]
Subtotal (95% CI) 28 24 100.0 % 12.64 [ 5.50, 19.77 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 3.47 (P = 0.00052)
2 SF-36 MCS score
Lord 2010 15 2.5 (20.9) 13 -3.2 (10.5) 60.1 % 5.70 [ -6.32, 17.72 ]
Lord 2012 13 9.3 (25.3) 11 4.3 (9) 39.9 % 5.00 [ -9.75, 19.75 ]
Subtotal (95% CI) 28 24 100.0 % 5.42 [ -3.90, 14.74 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.25)
Test for subgroup differences: Chi2 = 1.45, df = 1 (P = 0.23), I2 =31%
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Analysis 1.3. Comparison 1 Intervention - Singing vs Control, Outcome 3 Dyspnoea (mean change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 3 Dyspnoea (mean change)
Study or subgroup Singing Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 BDI (score)
Bonilha 2009 15 0.7 (1.2) 15 0.3 (1.7) 0.40 [ -0.65, 1.45 ]
-4 -2 0 2 4
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Analysis 1.4. Comparison 1 Intervention - Singing vs Control, Outcome 4 Respiratory muscle strength
(mean change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 4 Respiratory muscle strength (mean change)
Study or subgroup Singing Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 PImax (cmH2O)
Bonilha 2009 15 3 (19.2) 15 -1 (15.5) 4.00 [ -8.49, 16.49 ]
2 PEmax (cmH2O)
Bonilha 2009 15 3 (17.2) 15 -11.3 (20.2) 14.30 [ 0.87, 27.73 ]
-20 -10 0 10 20
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Analysis 1.5. Comparison 1 Intervention - Singing vs Control, Outcome 5 Pulmonary function (mean
change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 5 Pulmonary function (mean change)
Study or subgroup Singing Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 FEV1 (L)
Bonilha 2009 15 -0.03 (0.31) 15 0 (0.14) -0.03 [ -0.20, 0.14 ]
2 FVC (L)
Bonilha 2009 15 -0.14 (0.48) 15 -0.1 (0.3) -0.04 [ -0.33, 0.25 ]
3 FEV1/FVC (%)
Bonilha 2009 15 1.9 (8.3) 15 1.5 (2.9) 0.40 [ -4.05, 4.85 ]
4 ERV (L)
Bonilha 2009 15 0.06 (0.4) 15 -0.11 (0.2) 0.17 [ -0.06, 0.40 ]
5 IC (L)
Bonilha 2009 15 -0.09 (0.3) 15 0.07 (0.3) -0.16 [ -0.37, 0.05 ]
-4 -2 0 2 4
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Analysis 1.6. Comparison 1 Intervention - Singing vs Control, Outcome 6 Psychological status (mean
change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 6 Psychological status (mean change)
Study or subgroup Singing Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 HADS - anxiety score
Lord 2010 15 -1.1 (2.7) 13 0.8 (1.7) 59.6 % -1.90 [ -3.55, -0.25 ]
Lord 2012 13 -0.8 (3.6) 11 -0.9 (2.3) 40.4 % 0.10 [ -2.28, 2.48 ]
Subtotal (95% CI) 28 24 100.0 % -1.09 [ -3.02, 0.83 ]
Heterogeneity: Tau2 = 0.91; Chi2 = 1.83, df = 1 (P = 0.18); I2 =45%
Test for overall effect: Z = 1.11 (P = 0.27)
2 HADS - depression score
Lord 2010 15 -1.1 (2.5) 13 -0.1 (1.7) 67.8 % -1.00 [ -2.57, 0.57 ]
Lord 2012 13 -1.3 (3.8) 11 -0.7 (1.6) 32.2 % -0.60 [ -2.87, 1.67 ]
Subtotal (95% CI) 28 24 100.0 % -0.87 [ -2.16, 0.42 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.85), I2 =0.0%
-4 -2 0 2 4
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Analysis 1.7. Comparison 1 Intervention - Singing vs Control, Outcome 7 Peak exercise capacity (mean
change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 7 Peak exercise capacity (mean change)
Study or subgroup Singing Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 ISWT - metres
Lord 2010 15 26 (52.6) 13 11.3 (83) 34.2 % 14.70 [ -37.69, 67.09 ]
Lord 2012 13 -7.2 (46.1) 11 14.5 (38) 65.8 % -21.70 [ -55.35, 11.95 ]
Subtotal (95% CI) 28 24 100.0 % -9.26 [ -43.10, 24.57 ]
Heterogeneity: Tau2 = 157.92; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
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Analysis 1.8. Comparison 1 Intervention - Singing vs Control, Outcome 8 Physical activity level (mean
change).
Review: Singing for adults with chronic obstructive pulmonary disease (COPD)
Comparison: 1 Intervention - Singing vs Control
Outcome: 8 Physical activity level (mean change)
Study or subgroup Singing Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Sedentary time (minutes per day)
Lord 2012 13 -35.9 (127.3) 11 -27.3 (67) -8.60 [ -88.33, 71.13 ]
2 Steps (steps per day)
Lord 2012 13 -763 (1647) 11 1011 (1003) -1774.00 [ -2847.73, -700.27 ]
3 Physical activity duration (minutes per day)
Lord 2012 13 -92.7 (216.9) 11 49.5 (40.9) -142.20 [ -262.56, -21.84 ]
4 Active energy expenditure (kJ per day)
Lord 2012 13 -144.2 (436) 11 228.8 (146.3) -373.00 [ -625.28, -120.72 ]
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A P P E N D I C E S
Appendix 1. Sources and search methods for the Cochrane Airways Group Specialised Register
(CAGR)
Electronic searches: core databases
Database Frequency of search
CENTRAL (the Cochrane Library) Monthly
MEDLINE (Ovid) Weekly
Embase (Ovid) Weekly
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(Continued)
PsycINFO (Ovid) Monthly
CINAHL (EBSCO) Monthly
AMED (EBSCO) Monthly
Handsearches: core respiratory conference abstracts
Conference Years searched
AmericanAcademyofAllergy, Asthma and Immunology (AAAAI) 2001 onwards
American Thoracic Society (ATS) 2001 onwards
Asia Pacific Society of Respirology (APSR) 2004 onwards
British Thoracic Society Winter Meeting (BTS) 2000 onwards
Chest Meeting 2003 onwards
European Respiratory Society (ERS) 1992, 1994, 2000 onwards
International PrimaryCareRespiratoryGroupCongress (IPCRG) 2002 onwards
Thoracic Society of Australia and New Zealand (TSANZ) 1999 onwards
MEDLINE search strategy used to identify trials for the CAGR
COPD search
1. Lung Diseases, Obstructive/
2. exp Pulmonary Disease, Chronic Obstructive/
3. emphysema$.mp.
4. (chronic$ adj3 bronchiti$).mp.
5. (obstruct$ adj3 (pulmonary or lung$ or airway$ or airflow$ or bronch$ or respirat$)).mp.
6. COPD.mp.
7. COAD.mp.
8. COBD.mp.
9. AECB.mp.
10. or/1-9
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Filter to identify RCTs
1. exp “clinical trial [publication type]”/
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
We will adapt the MEDLINE strategy and RCT filter to identify trials in other electronic databases.
Appendix 2. Search strategy to identify relevant trials from the CAGR
#1 MeSH DESCRIPTOR Pulmonary Disease, Chronic Obstructive Explode All
#2 MeSH DESCRIPTOR Bronchitis, Chronic
#3 (obstruct*) near3 (pulmonary or lung* or airway* or airflow* or bronch* or respirat*)
#4 COPD:MISC1
#5 (COPD OR COAD OR COBD OR AECOPD):TI,AB,KW
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 (sing or singing or singer* or song*):ti,ab,kw
#8 (voice* or vocal*) NEAR (exercis* or train*)
#9 diaphragm* NEAR2 breath*
#10 MeSH DESCRIPTOR Music Therapy
#11 choir*:ti,ab,kw
#12 #7 or #8 or #9 or #10 or #11
#13 #6 AND #12
[in search line #4, MISC1 denotes the field in the record where the reference has been coded for condition, in this case, COPD]
C O N T R I B U T I O N S O F A U T H O R S
RJM: protocol initiation, development and writing; additional literature search; retrieval of papers; study screening, quality appraisal
and data extraction; author contact; data entry; data analysis; data interpretation; manuscript writing.
CE: protocol development and writing; additional literature search; retrieval of papers; study screening, quality appraisal and data
extraction; data analysis; data interpretation; manuscript writing.
EC: protocol development and writing; data interpretation; manuscript writing; manuscript review.
ZJM: protocol development and writing; data interpretation; manuscript review.
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D E C L A R A T I O N S O F I N T E R E S T
RJM: none known.
CE: none known.
EC: none known.
ZJM: none known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Cochrane Complementary Medicine Field bursary, USA.
Financial support received by RJM to facilitate completion of the review
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added clarification regarding the types of interventions: the criterion ’in the case of interventions combining one ormore components
of music therapy, for example instrumental and singing training, the singing must form the majority of the intervention’ was added.
Summary of findings table: only the primary outcomes of health-related quality of life and dyspnoea were reported. Secondary outcomes
of respiratory muscle strength and adverse events were not added due to only one study and no data, respectively, being available.
Subgroup and sensitivity analyses were not performed due to the small number of trials included.
Heterogeneity was considered significant if the P value was less than 0.10 (Higgins 2011).
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